ARCHIVES

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

This article is from The Cancer Letter archive.

Vol. 04 No. 43 | October 27, 1978

Download PDF Visit The Full Archive

Related Articles

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

November 28, 2014

UICC Names Banker As Chief Executive

September 11, 2009

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990